Philip Lee

Company: Senti Biosciences

Job title: Chief Technology Officer

Seminars:

Improving GMP Manufacturing of Allogeneic NK Cell Therapies: Assessment of NK Activation and Expansion Technologies 4:00 pm

Sharing experience of setting up GMP grade manufacturing for cell therapies Discussing the need for feeder cells, safety precautions, and how to demonstrate safety and purity Highlighting the key considerations and lessons learned in taking a product from preclinical development to GMP manufacturing and remaining areas of improvementRead more

day: Day One